002399 海普瑞
已收盘 11-12 15:00:00
资讯
新帖
简况
海普瑞新注册《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权
证券之星 · 11-07
海普瑞新注册《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权
股市必读：海普瑞三季报 - 第三季度单季净利润同比下降9.95%
证券之星 · 11-02
股市必读：海普瑞三季报 - 第三季度单季净利润同比下降9.95%
图解海普瑞三季报：第三季度单季净利润同比下降9.95%
证券之星 · 10-30
图解海普瑞三季报：第三季度单季净利润同比下降9.95%
海普瑞（002399）披露2026年三季度报告，10月29日股价下跌1.41%
证券之星 · 10-29
海普瑞（002399）披露2026年三季度报告，10月29日股价下跌1.41%
海普瑞(09989)：陈佩贞获委任为联席公司秘书、授权代表及代理人
智通财经 · 10-29
海普瑞(09989)：陈佩贞获委任为联席公司秘书、授权代表及代理人
海普瑞(09989)前三季度归母净利润3.94亿元 同比减少28.84%
智通财经 · 10-29
海普瑞(09989)前三季度归母净利润3.94亿元 同比减少28.84%
海普瑞（002399）9月30日主力资金净买入151.77万元
证券之星 · 10-08
海普瑞（002399）9月30日主力资金净买入151.77万元
海普瑞（002399）9月28日主力资金净买入397.87万元
证券之星 · 09-29
海普瑞（002399）9月28日主力资金净买入397.87万元
股市必读：海普瑞新发布《深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会法律意见书》
证券之星 · 09-23
股市必读：海普瑞新发布《深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会法律意见书》
海普瑞：上半年核心制剂业务持续增长
经济参考网 · 09-14
海普瑞：上半年核心制剂业务持续增长
海普瑞（002399）披露召开2026年第一次临时股东会通知，8月28日股价下跌1.42%
证券之星 · 08-28
海普瑞（002399）披露召开2026年第一次临时股东会通知，8月28日股价下跌1.42%
海普瑞：上半年净利润2.75亿元，同比减少34.74%
南方财经网 · 08-28
海普瑞：上半年净利润2.75亿元，同比减少34.74%
股市必读：海普瑞（002399）8月14日董秘有最新回复
证券之星 · 08-17
股市必读：海普瑞（002399）8月14日董秘有最新回复
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
智通财经网 · 07-02
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
海普瑞涨超3%
每日经济新闻 · 06-23
海普瑞涨超3%
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
智通财经 · 06-23
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
智通财经 · 05-26
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
海普瑞将于7月22日派发末期股息每10股1.6604港元
新浪港股 · 05-24
海普瑞将于7月22日派发末期股息每10股1.6604港元
海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%
证券之星 · 05-22
海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
智通财经 · 05-22
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
暂无数据
公司概况
公司名称：
深圳市海普瑞药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-06
主营业务：
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化，致力于为全球患者带去高质量的安全有效药物和服务。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。
发行价格：
148.00
{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.25,"timestamp":1794466986000,"preClose":9.25,"halted":0,"volume":2112520,"delay":0,"changeRate":0,"floatShares":1247000000,"shares":1467000000,"eps":0.1294,"marketStatus":"已收盘","change":0,"latestTime":"11-12 15:00:00","open":9.25,"high":9.32,"low":9.17,"amount":19517600,"amplitude":0.0162,"askPrice":9.25,"askSize":15,"bidPrice":9.24,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.1294,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":9.25,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":10.18,"lowLimit":8.33,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.13,"roa":"--","peRate":71.483771,"roe":"3.27%","epsLYR":0.2382,"committee":0.173093,"marketValue":13572000000,"turnoverRate":0.0017,"status":2,"hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.01,"timestamp":1794470884903,"preClose":4.015,"halted":0,"volume":474000,"delay":0,"premium":"-63.12"},"floatMarketCap":11537000000},"requestUrl":"/m/hq/s/002399/tweets","defaultTab":"tweets","newsList":[{"id":"2681133813","title":"海普瑞新注册《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2681133813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681133813?lang=zh_cn&edition=full","pubTime":"2026-11-07 09:39","pubTimestamp":1794015540,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海普瑞（002399）新注册了《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权。今年以来海普瑞新注册软件著作权1个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了8232.97万元，同比减19.85%。通过天眼查大数据分析，深圳市海普瑞药业集团股份有限公司共对外投资了14家企业，参与招投标项目34次；财产线索方面有商标信息121条，专利信息55条，著作权信息4条；此外企业还拥有行政许可131个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700010356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","BK0239","BK0070","BK1191","BK0188","002399","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680781827","title":"股市必读：海普瑞三季报 - 第三季度单季净利润同比下降9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680781827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680781827?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:54","pubTimestamp":1793584480,"startTime":"0","endTime":"0","summary":"业绩披露要点：海普瑞2026年前三季度归母净利润3.94亿元，同比下降28.84%；扣非净利润2.41亿元，同比下降56.24%。公司公告汇总2026年三季度报告海普瑞2026年第三季度报告显示，本报告期营业收入1,217,331,210.60元，同比下降11.60%；归属于上市公司股东的净利润118,613,610.40元，同比下降9.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200006657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679801102","title":"图解海普瑞三季报：第三季度单季净利润同比下降9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679801102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679801102?lang=zh_cn&edition=full","pubTime":"2026-10-30 01:58","pubTimestamp":1793296687,"startTime":"0","endTime":"0","summary":"证券之星消息，海普瑞2026年三季报显示，前三季度公司主营收入37.97亿元，同比下降9.48%；归母净利润3.94亿元，同比下降28.84%；扣非净利润2.41亿元，同比下降56.24%；其中2026年第三季度，公司单季度主营收入12.17亿元，同比下降11.6%；单季度归母净利润1.19亿元，同比下降9.95%；单季度扣非净利润7956.87万元，同比下降36.72%；负债率27.23%，投资收益2873.77万元，财务费用2.08亿元，毛利率34.37%。财报数据概要请见下图:本文数据来源于海普瑞2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000004161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679289558","title":"海普瑞（002399）披露2026年三季度报告，10月29日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679289558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679289558?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:42","pubTimestamp":1793284958,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，海普瑞报收于9.08元，较前一交易日下跌1.41%，最新总市值为133.23亿元。该股当日开盘9.18元，最高9.24元，最低9.07元，成交额达1830.96万元，换手率为0.16%。近日，海普瑞披露《2026年三季度报告》。报告显示，本报告期营业收入1,217,331,210.60元，同比下降11.60%；归属于上市公司股东的净利润118,613,610.40元，同比下降9.95%。年初至报告期末营业收入3,796,852,981.20元，同比下降9.48%；归属于上市公司股东的净利润393,898,350.51元，同比下降28.84%。扣除非经常性损益后的净利润为241,469,533.96元，同比下降56.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900063773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK0070","BK1191","09989","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679473941","title":"海普瑞(09989)：陈佩贞获委任为联席公司秘书、授权代表及代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2679473941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679473941?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:45","pubTimestamp":1793263527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，陈诗婷女士由于工作安排调整，已辞任本公司联席公司秘书及根据香港联合交易所有限公司证券上市规则第3.05条的授权代表自2026年10月29日起生效。董事会进一步宣布陈女士及黄慧儿女士已辞任根据上市规则第19.05(2)条规定代表本公司在香港接收法律程序文件及通知的代理人，自2026年10月29日起生效。陈佩贞女士已获委任为联席公司秘书、授权代表及代理人，自2026年10月29日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","002399","BK0070","BK0239","BK0188","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679473910","title":"海普瑞(09989)前三季度归母净利润3.94亿元 同比减少28.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679473910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679473910?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:44","pubTimestamp":1793263481,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布2026年前三季度业绩，该集团取得营业收入37.97亿元人民币，同比减少9.48%;归属于上市公司股东的净利润3.94亿元，同比减少28.84%;基本每股收益0.2685元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515078.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049099","title":"海普瑞（002399）9月30日主力资金净买入151.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049099?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:09","pubTimestamp":1791421740,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，海普瑞报收于9.85元，上涨2.5%，换手率0.33%，成交量4.15万手，成交额4078.03万元。近5日资金流向一览见下表：海普瑞融资融券信息显示，融资方面，当日融资买入194.78万元，融资偿还676.35万元，融资净偿还481.57万元。海普瑞主营业务：肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1191","BK0070","BK0239","002399","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261838","title":"海普瑞（002399）9月28日主力资金净买入397.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671261838?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:09","pubTimestamp":1790644143,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，海普瑞报收于9.66元，上涨0.84%，换手率0.26%，成交量3.23万手，成交额3111.17万元。近5日资金流向一览见下表：海普瑞融资融券信息显示，融资方面，当日融资买入426.65万元，融资偿还351.53万元，融资净买入75.11万元。海普瑞主营业务：肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","09989","BK1191","BK0239","002399","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669396121","title":"股市必读：海普瑞新发布《深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669396121","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669396121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:18","pubTimestamp":1790101090,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会决议公告深圳市海普瑞药业集团股份有限公司于2026年9月22日召开2026年第一次临时股东会，会议由董事会召集，董事长李锂主持，采取现场与网络投票结合方式召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","09989","BK0070","002399","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631936","title":"海普瑞：上半年核心制剂业务持续增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631936","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667631936?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:38","pubTimestamp":1789385903,"startTime":"0","endTime":"0","summary":"近日，海普瑞发布2026年半年度报告。报告期内，公司实现营业收入25.8亿元，归属于上市公司股东的净利润2.75亿元。上半年，海普瑞在高端制剂制造领域也取得重要进展。公司坪山预灌封制剂智造项目获得2026国际制药工程协会（ISPE）年度设施奖（FOYA）“创新-新技术”类别奖。制剂业务是海普瑞上半年经营中的突出亮点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873589764.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873589764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","09989","BK0070","BK0239","BK0188","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662109127","title":"海普瑞（002399）披露召开2026年第一次临时股东会通知，8月28日股价下跌1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662109127","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662109127?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:40","pubTimestamp":1787928040,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，海普瑞报收于10.45元，较前一交易日下跌1.42%，最新总市值为153.33亿元。该股当日开盘10.51元，最高10.59元，最低10.42元，成交额达5608.99万元，换手率为0.43%。近日，深圳市海普瑞药业集团股份有限公司披露《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年9月22日召开2026年第一次临时股东会，会议由董事会召集，现场会议时间为当日14:00，网络投票时间为同日9:15至15:00。股权登记日为2026年9月15日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800055479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399","BK0070","BK0239","BK0188","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662793068","title":"海普瑞：上半年净利润2.75亿元，同比减少34.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662793068","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662793068?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:53","pubTimestamp":1787907180,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电，海普瑞发布半年度报告，报告期内公司实现营业收入25.80亿元，同比下降8.44%；归属于上市公司股东的净利润2.75亿元，同比下降34.74%；归属于上市公司股东的扣除非经常性损益的净利润1.62亿元，同比下降62.01%；基本每股收益0.19元，同比下降34.75%；加权平均净资产收益率2.28%。公司计划不派发现金红利，不送红股，不以公积金转增股本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858212098.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858212098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170257","title":"股市必读：海普瑞（002399）8月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170257?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:34","pubTimestamp":1786905254,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，海普瑞报收于10.61元，下跌1.12%，换手率0.68%，成交量8.46万手，成交额8992.37万元。董秘最新回复投资者： 董秘，您好！当日关注点交易信息汇总：8月14日主力资金净流出326.7万元，占总成交额3.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","002399","BK1191","BK0239","09989","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502516","title":"股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502516","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648502516?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:59","pubTimestamp":1782989980,"startTime":"0","endTime":"0","summary":"6月30日，股东洪泽君增持海普瑞(09989)32.85万股，每股作价3.986港元，总金额约为130.94万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09989","002399","BK1191","BK0239","EWH","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883271","title":"海普瑞涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883271","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645883271?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:51","pubTimestamp":1782197486,"startTime":"0","endTime":"0","summary":"6月23日，海普瑞(09989.HK)涨超3%，早盘一度涨逾14%。截至发稿，涨2.6%，报3.95港元，成交额1475.14万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779660254.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779660254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","BK0070","BK1191","09989","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645916883","title":"港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2645916883","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645916883?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:40","pubTimestamp":1782196835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海普瑞涨超3%，早盘一度涨逾14%。消息面上，据海普瑞药业官微消息，近日，海普瑞药业宣布，集团全球制剂业务的核心承载主体、旗下全资子公司天道医药的依诺肝素钠注射液在肯尼亚获得批准。这是海普瑞旗下依诺肝素钠注射液在非洲获批的第四个国家，至此，该产品全球获批国家和地区数量增至80个。目前，海普瑞药业依托深圳市南山、坪山两大制剂生产基地，已形成年产5.5亿支依诺肝素钠注射液的世界级规模化产能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK4588","BK0239","09989","VXUS","002399","BK1191","BK4585","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638592398","title":"海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638592398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638592398?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:32","pubTimestamp":1779784346,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，将于2026年6月18日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK4588","002399","BK4585","BK0239","BK0188","VIG","EWH","BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637130308","title":"海普瑞将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637130308","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637130308?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:54","pubTimestamp":1779612840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 海普瑞（09989）发布公告，将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-24/doc-inhyytnk3405613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","BK0239","BK0188","BK1191","BK4585","09989","VIG","BK0070","BK4588","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334860","title":"海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334860","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637334860?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:39","pubTimestamp":1779460755,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，海普瑞报收于10.19元，较前一交易日下跌0.1%，最新总市值为149.52亿元。公告显示，公司于2026年5月22日召开2025年度股东会及第七届董事会第一次会议，完成董事会换届选举，并聘任高级管理人员及证券事务代表。同时选举产生董事会各专门委员会成员。公司聘任单宇为总经理，李坦为副总经理，陈娟为财务负责人，钱风奇为董事会秘书，张文为证券事务代表。相关人员均已取得相应资格证书，具备任职资格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1191","002399","09989","161027","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312478","title":"海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312478","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637312478?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:22","pubTimestamp":1779456151,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","BK1191","BK0188","002399","BK4588","BK4585","EWH","BK0070","BK0239","VIG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794522561257,"stockEarnings":[{"period":"1week","weight":-0.0365},{"period":"1month","weight":-0.0385},{"period":"3month","weight":-0.1282},{"period":"6month","weight":-0.0908},{"period":"1year","weight":-0.2406},{"period":"ytd","weight":-0.2027}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0382},{"period":"3month","weight":-0.0691},{"period":"6month","weight":-0.116},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.0789}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":" 深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化，致力于为全球患者带去高质量的安全有效药物和服务。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。","listedPrice":148},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}